INIS
risks
100%
patients
43%
genetics
41%
spectra
36%
symptoms
33%
populations
31%
control
28%
liabilities
23%
psychoses
21%
data
20%
sex
20%
brain
17%
performance
15%
levels
15%
comparative evaluations
14%
interactions
14%
genes
10%
reviews
10%
antidepressants
10%
mental disorders
9%
stratification
9%
prediction
9%
therapy
9%
alcohols
9%
inflammation
9%
specifications
9%
electroencephalography
9%
loading
9%
antibodies
9%
testing
9%
Keyphrases
Schizophrenia
85%
Polygenic Risk Score
47%
Exposome
30%
Psychotic Experiences
28%
Patients with Schizophrenia
27%
Healthy Controls
26%
Schizophrenia Spectrum Disorders
25%
Genetic Risk
21%
Sibling Controls
19%
Clozapine
19%
Control Results
19%
UK Biobank
19%
Psychosis
13%
Cannabis Use
13%
Major Depressive Disorder
13%
Social Cognition
11%
Symptom Severity
10%
Polygenic Risk Score Analysis
10%
Longitudinal Association
10%
Risk Scoring
9%
Functional Interpretation
9%
Electroconvulsive Therapy
9%
Structural Brain Changes
9%
Genome-wide Association Analysis
9%
Facial Emotion Recognition
9%
Cortical Thickness
9%
First-episode Psychosis
9%
Mental Disorders
9%
Non-genetic Factors
9%
Temporal Expression Pattern
9%
